• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

63
4
2
2
2

COUNTRY

4
2
2
1
1

CATEGORIES

  • 62
  • 41
  • 35
  • 17
  • 12
  • 10
  • 6
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

90
103
127
162

PUBLISHED

6
35
53
162

PRODUCT TYPE

84
70
7
1

Search "The Biology and Treatment of Cancer: Understanding Cancer - DUPLICATE" returned 162 results.

PRODUCT TITLE
Drug Delivery in Cancer - Technologies, Markets and Companies Drug Delivery in Cancer - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

December 2014
FROM
Personalized Medicine - Scientific and Commercial Aspects Personalized Medicine - Scientific and Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

December 2014
FROM
Biomarkers - Technologies, Markets and Companies Biomarkers - Technologies, Markets and Companies - Product Thumbnail Image

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

December 2014
FROM

Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise

GBI Research, the leading business intelligence provider, has released its latest research, “Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer...

July 2012
FROM

Cancer Stem Cells. Identification and Targets

Because the concept and discoveries of cancer stem cells are relatively new, scientists and researchers need an introduction to this dynamic area. Cancer Stem Cells presents a consolidated account of...

November 2008
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities - Product Thumbnail Image

Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities

In a market currently valued around US$42 billion, cancer chemotherapies are on course for staggering growth potential and may revolutionize cancer treatments over the next 10 years according to a new...

April 2006
FROM

Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Nasopharyngeal Cancer Therapeutics...

February 2012
FROM
The Molecular Biology of Cancer. A Bridge from Bench to Bedside. 2nd Edition The Molecular Biology of Cancer. A Bridge from Bench to Bedside. 2nd Edition - Product Thumbnail Image

The Molecular Biology of Cancer. A Bridge from Bench to Bedside. 2nd Edition

The Molecular Biology of Cancer, Stella Pelengaris & Michael Khan  This capturing, comprehensive text, extensively revised and updated for its second edition, provides a detailed overview of the...

April 2013

The Molecular Biology of Cancer. A Bridge from Bench to Bedside. 2nd Edition

The Molecular Biology of Cancer, Stella Pelengaris & Michael Khan  This capturing, comprehensive text, extensively revised and updated for its second edition, provides a detailed overview of the...

April 2013
FROM
Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018 Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018 - Product Thumbnail Image

Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018

Circulating tumor cell technology is an enabling technology for recovery and analysis of separated cancer cells in the peripheral blood CTC technology offers advantages like high sensitivity, high specificity,...

August 2012
FROM
Cancer Vaccines: Measuring Market Potential Cancer Vaccines: Measuring Market Potential - Product Thumbnail Image

Cancer Vaccines: Measuring Market Potential

This brand new report published in October 2004 provides an overview of the emerging market for cancer vaccines and measures their potential impact on a number of cancer markets. Vaccine product...

October 2004
FROM

Oncology at a Glance. At a Glance

This brand new title in the market-leading at a Glance series brings together fundamental information on cancer biology and treatment to provide a holistic understanding of oncology. It explores both...

April 2013

Cancer Immunotherapy. Edition No. 2

There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression...

July 2013

Gene Therapy of Cancer. Edition No. 3

Gene therapy as a treatment for cancer is at a critical point in its evolution. Exciting new developments in gene targeting and vector technology, coupled with results from the first generation of preclinical...

October 2013

Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation

Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation provides clinical and scientific researchers with a deep understanding of the current research in this field and the implications...

January 2013
Pain Therapeutics - Drugs, Markets and Companies Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic...

December 2014
FROM
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success - Product Thumbnail Image

Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success

This is a unique and unrivalled 367-page report analysing the performance of numerous important early stage oncology drug candidates, assessing their market viability based on preclinical scientific...

November 2006
FROM

Oxford Gene Technology - Product Pipeline Analysis

Summary Oxford Gene Technology (OGT) is a private biotechnology company, based in the UK. The company develops biomarkers. Its patent protected technologies include southern blotting and microarray...

November 2012
FROM

Molecular Biology of Cancer: Translation to the Clinic, Vol 95

Advances in molecular biology over the last several decades are being steadily applied to our understanding of the molecular biology of cancer, and these advances in knowledge are being translated into...

December 2010
Molecular Diagnostics and Treatment of Pancreatic Cancer Molecular Diagnostics and Treatment of Pancreatic Cancer - Product Thumbnail Image

Molecular Diagnostics and Treatment of Pancreatic Cancer

Molecular Diagnostics and Treatment of Pancreatic Cancer describes the different emerging applications of systems biology and how it is shaping modern pancreatic cancer research. This book begins by...

April 2014
Loading Indicator

Our Clients

Our clients' logos